SOTERA HEALTH COMPANY Comprehensive Income
SOTERA HEALTH COMPANY (SHC) reported Comprehensive Income of $36.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- SOTERA HEALTH COMPANY comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $36.13M, a 59.46% decline year-over-year.
- SOTERA HEALTH COMPANY comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $10.49M, a 89.36% increase year-over-year.
- SOTERA HEALTH COMPANY comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was $89.13M.
- SOTERA HEALTH COMPANY comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was $5.54M.
- SOTERA HEALTH COMPANY comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $176.36M.
- SOTERA HEALTH COMPANY comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$71.17M, a 208.91% decline from fiscal 2023.
- SOTERA HEALTH COMPANY comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $65.35M.
- SOTERA HEALTH COMPANY comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$256.66M, a 301.84% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $36.13M 10-Q · filed 2026-08-06 | $46.62M 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $10.49M 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $176.36M 10-K · filed 2026-02-24 | |||
| 2025-06-30 | $89.13M 10-Q · filed 2026-08-06 | $94.67M 10-Q · filed 2026-08-06 | $23.36M derived: sum of 3 quarters · filed 2026-08-06 | $61.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $5.54M 10-Q · filed 2026-05-05 | -$65.77M derived: sum of 2 quarters · filed 2026-05-05 | -$28.00M derived: sum of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$71.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$33.53M derived: sum of 2 quarters · filed 2026-02-24 | -$71.17M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $37.78M 10-Q · filed 2024-11-05 | $138.00K 10-Q · filed 2024-11-05 | ||
| 2023-12-31 | $60.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $11.64M derived: sum of 2 quarters · filed 2026-02-24 | $65.35M 10-K · filed 2026-02-24 | |
| 2023-09-30 | -$48.50M 10-Q · filed 2024-11-05 | $5.21M 10-Q · filed 2024-11-05 | ||
| 2022-12-31 | -$262.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$296.27M derived: sum of 2 quarters · filed 2025-02-27 | -$308.18M derived: sum of 3 quarters · filed 2025-02-27 | -$256.66M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$33.90M 10-Q · filed 2023-11-01 | -$45.81M derived: sum of 2 quarters · filed 2023-11-01 | $5.71M 10-Q · filed 2023-11-01 | $64.10M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$11.91M 10-Q · filed 2022-08-04 | $39.61M 10-Q · filed 2022-08-04 | $97.99M derived: sum of 3 quarters · filed 2024-02-27 | $96.95M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $51.52M 10-Q · filed 2022-05-05 | $109.90M derived: sum of 2 quarters · filed 2024-02-27 | $108.86M derived: sum of 3 quarters · filed 2024-02-27 | $171.16M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $58.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $57.34M derived: sum of 2 quarters · filed 2024-02-27 | $119.64M derived: sum of 3 quarters · filed 2024-02-27 | $127.16M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$1.04M 10-Q · filed 2022-11-02 | $61.25M derived: sum of 2 quarters · filed 2022-11-02 | $68.78M 10-Q · filed 2022-11-02 | $56.42M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $62.29M 10-Q · filed 2022-08-04 | $69.81M 10-Q · filed 2022-08-04 | $57.46M derived: sum of 3 quarters · filed 2023-02-28 | $75.99M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $7.52M 10-Q · filed 2022-05-05 | -$4.83M derived: sum of 2 quarters · filed 2023-02-28 | $13.70M derived: sum of 3 quarters · filed 2023-02-28 | $45.65M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.17M derived: sum of 2 quarters · filed 2023-02-28 | $38.13M derived: sum of 3 quarters · filed 2023-02-28 | -$38.07M 10-K · filed 2023-02-28 |
| 2020-09-30 | $18.53M 10-Q · filed 2021-11-10 | $50.48M derived: sum of 2 quarters · filed 2021-11-10 | -$25.72M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $31.96M 10-Q · filed 2021-08-12 | -$44.25M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$76.20M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$5.28M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |